Several checkpoint molecules, namely PD-1 on T cells, PD-L1 on tumor cells, and CTLA-4 on antigen-presenting cells or tumor cells, are most frequently researched in human cancer [86] (Figure 4). This evidence concerns the gene CTLA4 and neoplasm.